〔Day Digest〕Strong Jobs Print Resets the Path: UBS and Macquarie Bring September Hikes to the Table at 25bp, While Marks Calls the Tape 'Euphoria' - Hawkish Concurrence vs Stretched Valuation

0. Weekly Arc

The strong US jobs report has re-anchored the rate path higher: UBS Global Wealth Management now sees 25bp hikes in both September and December, a reversal from its prior 'hold' call, and Macquarie pulled its next move forward from December to September while keeping another 25bp penciled in for Q1 2027 ^[1][2]. Yet Oaktree's Howard Marks says US equities are in a clear state of 'euphoria' and that the current setup is one of the hardest he has faced in his career ^[3]. Net: a hawkish policy reset layered on top of a stretched tape.

1. Policy Narrative

• **[ESCALATED] UBS Global Wealth Management:** now forecasts 25bp Fed hikes in September and December 2026, having previously expected policy to remain unchanged ^[1]. Bank-channel coverage echoes the same call in the wake of the strong jobs print ^[4][5].
• **[NEW] Macquarie:** brought forward the next US Fed hike to September from December and still anticipates another 25bp increase in Q1 2027 ^[2].
• **[ONGOING] TD Securities:** inflation data continue to steer the Fed policy path, leaving the door open for incoming prints to redirect the trajectory ^[6].
• **Source quality control:** the Fed-timing revision is a cluster, not a point - UBS = Sep+Dec 2026, Macquarie = Sep 2026 + Q1 2027 ^[1][2].

2. Key Data and Market Read

• **[NEW] Strong US jobs report:** the trigger for the hawkish reset; cited by both UBS and Macquarie as the basis for pulling forward the rate path ^[4][5][1][2].
• **[NEW] KOSPI surge, Goldman 12,000 call:** Korean equities jumped over 3% intraday, reclaiming the 6,900 level, with SK Hynix +6% and Samsung Electronics +4%; foreign investors net bought KRW 890.7bn, institutions KRW 752.8bn, while retail sold KRW 2.2441tn on the day ^[7]. The bid is tied to OpenAI's GPT-6 Astra launch and the implied memory demand, with Goldman calling for KOSPI 12,000 ^[7].
• **[NEW] JPMorgan strategists (Mislav Matijka's team):** keep buying dips; non-US equities set to outperform US for a second year, EM > DM, semis stabilizing; mild tightening will not derail the equity bid provided inflation expectations stay anchored ^[8].
• **[NEW] Guotai Fund (semiconductors):** domestic equipment is in a 'golden window,' with YMTC's IPO accepted (target raise 33bn yuan) and accelerating NAND capacity build toward a #1 global share target by end-2027; sub-segments with low localization rates - metrology/inspection <5%, coater/developer near zero, high-end SoC and memory testers 8-10% - offer the cleanest substitution elasticities ^[9].

3. China Earnings and Sector Calls

• **[NEW] Goldman: China Q2 earnings growth hits a five-year high.** Net profit +14% y/y in H1 2026, with Q2 alone up 24% (highest in five years vs Q1 +6%); POE +36% and 'New China' +62% versus SOE +18% and 'Old China' +10%; STAR Market +102%, ChiNext +44%, CSI 500/1000 +27%/+22% ^[10]. MSCI China +16% but heavily financials-driven (+34% financials, ex-financials only +5%) ^[10]. Growth is broadening from AI hard tech into more sectors ^[10].
• **[NEW] CITIC Securities (electronics):** Q2 sector results strong, with profit growth far outpacing revenue, the AI cycle driving price-led inflation across the electronics stack ^[11].
• **[NEW] Huatai Securities (sodium battery):** the industry thesis has decoupled from lithium price; five application scenarios reach cost parity successively in 2026-2030, sodium battery demand 800/2,047 GWh in 2030/2035 with storage ~80%; 2027-2028 the capacity and order validation window, 2029 onward scale release ^[12].
• **[NEW] CITIC Securities (real estate):** argues the sector will take a 'de-manufacturing' path, pursuing personalized delivery and premium development; recommends developers with customization experience and property managers that can take on option-fitting services ^[13].

4. Single-Stock Calls

• **[NEW] Apple foldable cycle (Jefferies' Edison Lee, UBS' David Vogt):** incoming CEO John Ternus debuts his first product slate Wednesday, marking a 3-5 year cycle; Vogt models 10mn+ foldable units in year one (~4% of the ~250mn iPhone base) but a meaningful ASP lever, with a full iPhone line price hike expected ^[14].
• **[NEW] BYD (Dongfang Securities, Buy, target 125.28 yuan):** August sales 440,300 units, +17.8% y/y and +5.0% m/m; overseas 189,500 units, +134.4% y/y, 43.0% of total; H1 overseas revenue first exceeded domestic; 2026-28E EPS 4.64/5.39/6.18 yuan on 27x 2026E PE ^[15].
• **[NEW] Rongsheng Petrochemical (Dongfang Securities, Buy, target 16.59 yuan, prior 15.94):** H1 net profit 5.111bn yuan, +748.84% y/y; target on 15x 2026E PE ^[16].
• **[NEW] Hanrui Cobalt (BOC International, Overweight):** H1 revenue 3.907bn yuan, +23.32%; net profit 99mn yuan, -22.50%; 2026-28E EPS 0.79/1.15/1.44 yuan on 42.7/29.3/23.4x PE ^[17].
• **[NEW] Daimay (Dongfang Securities, Buy, target 14.40 yuan):** H1 net profit 420mn yuan, +74.2%; Q2 234mn, +623.3% y/y and +25.4% q/q; plans to acquire Rongming Technology into functional and surface parts; 100mn-yuan robotics subsidiary for e-skin and structural parts; 2026-28E net profit 1.034/1.111/1.220bn yuan on 30x 2026E PE ^[18].
• **[NEW] MiniMax (Guotai Haitong, Overweight, target HKD 449):** H1 revenue $117mn, +283.1% y/y; gross profit $20mn, +464.8%; gross margin 17.9%, +5.7pp; August ARR >$800mn, >400% growth in six months; 2026-28E revenue $0.5/1.46/3.57bn on 40x 2026E PS ^[19].
• **[NEW] Yilite (Guohai Securities, Buy):** Q2 net profit -23mn yuan, y/y swung to a loss; premium baijiu -64.1% in Q2 was the main drag; reform path tied to direct-to-terminal integration and price-band repair ^[20].
• **[NEW] Jinzhongzi Liquor (Guohai Securities, Overweight):** Q2 revenue ~46mn yuan, -75.6%; 2026-28E revenue 566/620/760mn yuan; net profit -76/-63/+33mn yuan, with the firm turning profitable in 2028 ^[21].

5. Policy and Capital Actions

• **[NEW] State-owned big bank capital injection:** ICBC and ABC disclosed plans to raise up to 260bn yuan combined (ICBC up to 100bn, ABC up to 160bn); at the cap, core Tier-1 ratios rise ~33bp/~61bp; the Ministry of Finance and China Tobacco-related entities are among the subscribers ^[22]. Combined with the 2025 520bn-yuan raise by BoC, CCB, BoComm and PSBC, the cumulative major-bank raise reaches 780bn yuan ^[22].
• **[NEW] Bank sector logic - 'slowing for quality' + higher payouts:** 21 listed banks announced 2026 interim dividends, 12 with payout ratios above 2025 full-year levels; H1 total assets +7.8% y/y (-1.5pp q/q), credit +6.5%, investment assets +14.1% ^[23].
• **[NEW] BSE industrial coatings (Kaiyuan):** China is the world's largest coatings market with output of 35.77/35.34/34.60mn tons in 2023-2025; high-end segments (marine, aerospace, wind, auto) carry the structural substitution runway ^[24].
• **[NEW] BSE buybacks and insider buying (Kaiyuan):** 2026 YTD actual buybacks 721mn yuan (highest since 2023), average per company 14.132mn yuan (+76.9% vs 2025); 59 companies disclosed plans up to 1.301bn yuan (+883.56% vs 2025); 37 plans priced at a premium, 29 of them >30% ^[25].

6. Contrarian and Tail Risks

• The Fed path is a spread, not a point: UBS = two 2026 hikes (Sep+Dec); Macquarie = Sep 2026 + Q1 2027; TD's framing leaves the door open for inflation data to redirect ^[6][1][2]. The falsifiable test is the next inflation print.
• The tape is stretched against the hawkish reset: Marks' 'euphoria' warning sits on top of UBS/Macquaire rate-hike calls, while JPMorgan keeps the buy-the-dip framework intact ^[3][8]. A hot CPI with a euphoric tape is the asymmetric risk.
• **Source quality control:** the KOSPI/Goldman 12,000 narrative is single-source relayed via a market note ^[7]; the BSE buyback/insider-buying data is from a single Kaiyuan report ^[25]; the Apple foldable unit estimate is a single UBS analyst ^[14]; the JPMorgan non-US-to-outperform-US call is a single desk view ^[8].